Core Viewpoint - Tianyu Biotechnology Co., Ltd. has announced the early repayment of part of the idle raised funds temporarily used to supplement working capital, ensuring that the repayment does not affect the implementation of the fundraising investment projects [1][2]. Group 1 - The company’s board of directors approved the continued use of up to RMB 61.5 million of idle raised funds to temporarily supplement working capital, with a usage period not exceeding twelve months from the date of approval [1]. - As of September 23, 2025, the company has repaid RMB 2 million to the special account for raised funds, bringing the total amount repaid to RMB 2 million [2]. - The remaining raised funds used for temporary working capital will be fully repaid before the due date, and the company will fulfill its information disclosure obligations in a timely manner [2].
天域生物科技股份有限公司 关于提前归还部分暂时用于补充流动资金的 闲置募集资金的公告